Description

1-Piperazinecarboxamide, 4-(2,3-Dichlorophenyl)-N,n-Dimethyl- is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of complex active pharmaceutical ingredients (APIs). This compound is critical for research and development in medicinal chemistry, offering a key building block for novel therapeutic agents. It is primarily utilized by pharmaceutical manufacturers and contract research organizations (CROs) focused on developing new drug candidates, particularly in the areas of central nervous system (CNS) and metabolic disorder treatments.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the multi-step synthesis of novel drug candidates and active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Serves as a crucial building block for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Contract Manufacturing: Used by CDMOs (Contract Development and Manufacturing Organizations) for the scale-up and production of clinical trial materials.
• Academic & Institutional Research: Employed in university and institutional labs for pharmacological studies and the development of new synthetic methodologies.
• Pre-clinical Development: Integral to the synthesis of compounds for pharmacokinetic, pharmacodynamic, and toxicology studies.

Basic Information

Product Name	1-Piperazinecarboxamide, 4-(2,3-Dichlorophenyl)-N,n-Dimethyl-
CAS No.	2327471-74-7
Molecular Formula	C13H17Cl2N3O
Molecular Weight	302.20 g/mol
Synonyms	4-(2,3-Dichlorophenyl)-N,N-dimethylpiperazine-1-carboxamide; N,N-Dimethyl-4-(2,3-dichlorophenyl)piperazine-1-carboxamide; 4-(2,3-Dichlorophenyl)-N,N-dimethyl-1-piperazinecarboxamide; 1-Piperazinecarboxamide, 4-(2,3-dichlorophenyl)-N,N-dimethyl-; UNII-9K6T2Y8W6P; 9K6T2Y8W6P; 2327471-74-7
EINECS	Contact for details

Quality Control

Our 1-Piperazinecarboxamide, 4-(2,3-Dichlorophenyl)-N,n-Dimethyl- is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation (IR, NMR), to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, residual solvents, and related substances is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storage under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Any single unknown impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Heavy Metals	≤ 20 ppm
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.